Nicholas J. Virca serves as Executive at HedgePath Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Nicholas J. Virca has executed 2 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Mar 8, 2017 involved selling 6,314,219 shares valued at $2.1M.
Nicholas J. Virca currently holds 8,727,519 shares of HedgePath Pharmaceuticals, Inc. (HPPI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Nicholas J. Virca has been a net neutral trader of HPPI stock. They have purchased $0 and sold $0 worth of shares.
Nicholas J. Virca's most recent insider trade was on Mar 8, 2017, when they sold 6,314,219 shares at $0.34 per share.
Get notified when new Form 4 filings are submitted
| 15,041,738 |
| $N/A |
| Discretionary |